Home /
Chemotherapy – National University Hospital, Rigshospitalet
|
|
Description: |
Patients: This Phase II study involved 26 patients with malignant mesothelioma. (24 patients had pleural mesothelioma.)
Treatment: The treatment consisted of administration of the chemotherapy drug, Ifosfamide (IFEX). Toxicity: Grade 3-4 toxicities included leucopenia, infection, nausea/vomiting, diarrhea, neurotoxicity, renal, hematuria, and alopecia. Results: The median overall survival was 10 months. |